NCT03183557

Efficacy of Zoledronic Acid in Osteoporosis

Examination of Bone Metabolism and Bone Mineral Density by Zoledronic Acid in Primary and Secondary Osteoporosis

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Shinshu University · Academic / Other
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

There has been no comparative data between Zoledronic acid and Zoledronic acid combined with active vitamin D in primary and secondary osteoporosis.

Conditions

• Osteoporosis

Interventions

Type	Name	Description
DRUG	"Zoledronic acid", "Reclast®"	To examine the efficacy of zoledronic acid in osteoporosis
DRUG	"Zoledronic acid", "Reclast®" and "active vitamin D", "alfacalcidol®"	To examine the efficacy of zoledronic acid plus alfacalcidol in osteoporosis

Timeline

• Start date: 2017-10-12
• Primary completion: 2022-12-08
• Completion: 2025-06-08
• First posted: 2017-06-12
• Last updated: 2021-09-21

Locations

1 site across 1 country: Japan